MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Investment Ideas Pro

Has Abbott Laboratories Just Redefined Its Future with Exact Sciences

5 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What Does UBS O'Connor's Big Bet on Exact Sciences Really Mean

4 months ago

Has Dolby Laboratories Found Its Groove in Q2 2026

3 months ago

Has Alumis's Envudeucitinib Redefined Psoriasis Treatment

4 months ago

What Does Medallia's Recapitalization Mean for Its Future

1 months ago

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know

Abbott Laboratories (ABT) is drawing increased investor attention on Zacks.com, driven by factors that could influence the stock's near-term prospects.

ABT

Stock News•1 months ago

Mounting Evidence Backs Abbott's Cancer Diagnostics Growth Story

Abbott's cancer diagnostics growth prospects strengthened by its Exact Sciences acquisition, supported by new data and updated screening guidelines.

ABT

Stock News•2 months ago

Abbott's CE Mark Win for Libre Duo Systems May Lift Its Stock

Abbott Laboratories received CE Mark approval for its Libre Duo systems, the first dual glucose-ketone sensors. The company plans to begin a European rollout later this year, expanding its portfolio o...

ABT

Stock News•3 months ago

Abbott Laboratories: Buying A Healthcare Giant On Sale

Abbott Laboratories shares fell ~35% to $92.48 as of April 23, 2026, from a March 2025 peak of $141.23. Management issued fiscal 2026 adjusted diluted EPS guidance of $5.38 to $5.58 following the comp...

ABT